Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis

PHASE3CompletedINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

February 27, 2015

Primary Completion Date

September 17, 2015

Study Completion Date

September 17, 2015

Conditions
Actinic Keratosis
Interventions
DRUG

Generic Fluorouracil Cream

Topical cream, generic formulation of the brand product.

DRUG

Carac® (Fluorouracil) Cream

Topical cream, brand product.

DRUG

Vehicle Cream

Topical cream, placebo. Has no active ingredient.

Trial Locations (17)

Unknown

Investigative Site 2, Fremont

Investigative Site 16, Los Angeles

Investigative Site 17, San Diego

Investigative Site 4, Denver

Investigative Site 10, Newnan

Investigative Site 5, Boise

Investigative Site 1, Arlington Heights

Investigative Site 11, Buffalo Grove

Investigative Site 3, Carmel

Investigative Site 9, Plainfield

Investigative Site 6, South Bend

Investigative Site 8, Clinton Township

Investigative Site 13, Warren

Investigative Site 12, Fridley

Investigative Site 15, Albuquerque

Investigative Site 7, High Point

Investigative Site 14, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT02616601 - Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | Biotech Hunter | Biotech Hunter